SCHEMBL9769122

SCHEMBL9769122

[CH2]c1csc(CCCCCC)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 4/20 0.37
ESR1 P03372 2/20 0.37
ADRA2A P08913 2/20 0.37
ADORA3 P0DMS8 2/20 0.37
TACR2 P21452 2/20 0.37
SLC6A2 P23975 2/20 0.37
SLC6A4 P31645 2/20 0.37
SLC6A3 Q01959 2/20 0.37
CYP3A4 P08684 2/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
SHBG P04278 1/20 0.37
TP53 P04637 1/20 0.37
HSPD1 P10809 1/20 0.37
ADRB3 P13945 1/20 0.37
HTR2C P28335 1/20 0.37
HSPE1 P61604 1/20 0.37
HIF1A Q16665 1/20 0.37
TST Q16762 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28814537 0.82 LTB4R (0.48) PTGS2ESR1ADRA2AADORA3TACR2
SCHEMBL8564302 0.82 LTB4R (0.48) PTGS2ESR1ADRA2AADORA3TACR2
SCHEMBL17707867 0.80 LTB4R (0.45) PTGS2ESR1ADRA2AADORA3TACR2
SCHEMBL3872581 0.78 GPR35 (0.40) PTGS2ESR1ADRA2AADORA3TACR2
SCHEMBL21953264 0.78 PTGS2 (0.39) PTGS2ESR1ADRA2AADORA3TACR2
SCHEMBL19304386 0.78 PTGS2 (0.38) PTGS2CYP3A4ALDH1A1GPR35
SCHEMBL3871459 0.78 GPR35 (0.40) PTGS2ESR1ADRA2AADORA3TACR2
SCHEMBL9769129 0.78 PTGS2 (0.38) PTGS2CYP3A4ALDH1A1GPR35
SCHEMBL3870570 0.78 GPR35 (0.40) PTGS2ESR1ADRA2AADORA3TACR2
SCHEMBL15791266 0.78 GPR35 (0.40) PTGS2ESR1ADRA2AADORA3TACR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4992534-A Anticarcinogenic agents with better water solubility, low toxicity, absorption and stability OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-02-12 US disclosed
CN-1031536-A 2 '-'-Deoxy-5-fluorouridine derivatives and its production and application OTSUKA PHARMA CO LTD (JP) 1989-03-08 CN disclosed
EP-0303269-A2 2'-Deoxy-5-fluorouridine derivatives, process for preparing the same and the use thereof OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1989-02-15 EP disclosed